[1]
EL-Mernissi, R. et al. 2022. 3D-QSAR, ADMET and Docking Studies for Design New 5,5-Diphenylimidazolidine-2,4-dione Derivatives Agents Against Cervical Cancer . Orbital: The Electronic Journal of Chemistry. 14, 1 (Apr. 2022), 24–32.